BioMarker Strategies announced today that it has appointed Glenn A. Miller, PhD, to its Board of Directors, where he will serve as Chairman. Dr. Miller had previously served on the company’s Scientific Advisory Board. The company also announced that its cofounder, Dr. Douglas P. Clark, will become the Chief Medical Officer and Acting CEO of the company starting July 1, 2011.
